Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD AND BACKGROUND OF THE INVENTION
The present invention relates to a novel treatment for metabolic syndrome and resulting complications, such as obesity, hypertension, hyperlipidemia, hyperinsulinemia and impaired glucose tolerance. In addition, it concerns the use of diazoxide for the treatment
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION
The present invention relates to Pyrimidine Derivatives, compositions comprising a Pyrimidine Derivative, and methods of using the Pyrimidine Derivatives for treating or preventing obesity, diabetes, a diabetic complication, a metabolic disorder, a cardiovascular disease or a
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims benefit under 35 U.S.C. .sctn.119 from Korean Patent Application No. 2004-112874, filed on Dec. 27, 2004, the entire content of which is incorporated herein by reference.
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
TECHNICAL FIELD
The present invention relates to glucopyopyranosyloxypyrazole derivatives, pharmaceutically acceptable salts thereof or prodrugs thereof which are useful as medicaments, production intermediates thereof and pharmaceutical uses thereof.
More particularly, the present invention relates
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
TECHNICAL FIELD
The present invention relates to glucokinase activators comprising an oxotetrahydrofuran-2-yl-benzimidazoles as an active ingredient thereof. The present invention further relates to a novel oxotetrahydrofuran-2-yl-benzimidazole derivative.
BACKGROUND ART
Glucokinase (gk) (atp:
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
TECHNICAL FIELD
The present invention relates to glucopyranosyloxybenzylbenzene derivatives and pharmaceutically acceptable salts thereof which are useful as medicaments and pharmaceutical uses thereof.
More particularly, the present invention relates to glucopyranosyloxybenzylbenzene derivatives
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
TECHNICAL FIELD
The present invention relates to glucopyranosyloxypyrazole derivatives, pharmaceutically acceptable salts thereof or prodrugs thereof which are useful as medicaments, production intermediates thereof and pharmaceutical uses thereof.
More particularly, the present invention relates to
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
This is a 371 of PCT/JP02/01707, and claims benefit from Japanese Applications 51278/2001 filed Feb. 26, 2001 and 52903/2001 filed Feb. 27, 2001, each of which is incorporated herein by reference.
TECHNICAL FIELD
The present invention relates to glucopyranosyloxypyrazole derivatives,
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
TECHNICAL FIELD
The present invention relates to glucopyranosyloxypyrazole derivatives, pharmaceutically acceptable salts thereof or prodrugs thereof which are useful as medicaments, pharmaceutical compositions containing the same, pharmaceutical uses thereof and production intermediates
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
TECHNICAL FIELD
The present invention relates to a glucokinase activator comprising an acetyl pyrrolidinyl indole derivative as the active ingredient thereof. Further, it relates to a novel acetyl pyrrolidinyl indole derivatives.
BACKGROUND ART
Glucokinase (GK) (ATP: D-hexose 6-phosphotransferaze,
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF INVENTION
The present invention relates to novel compounds represented by formula I, their derivatives, their analogs, their tautomeric forms, their stereoisomers, their bioisosters, their diastereomers, their polymorphs, their pharmaceutically acceptable salts, solvates and
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
FIELD OF THE INVENTION
The present invention relates to certain heterocyclic compounds useful as diacylglycerol acyltransferase ("DGAT") inhibitors, especially diacylglycerol acyltransferase 1 ("DGAT1") inhibitors, pharmaceutical compositions containing the compounds, and methods of treatment using
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to benzene compounds, and more particularly, to novel benzene compounds having inhibition activity on acetyl CoA carboxylase ("ACC" hereinafter).
2. Discussion of the Background
It has become clear in recent years
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
BACKGROUND TO THE INVENTION
The present invention relates to a series of benzimidazole compounds having hypoglycemic, anti-diabetic, anti-cataract and 5-lipoxygenase inhibitory activities, the ability to inhibit the formation of lipid peroxide and related activities, as described in more detail
Straipsnius versti gali tik registruoti vartotojai
Prisijungti Registracija
TECHNICAL FIELD
The present invention relates to a bicyclic compound having an acetyl-CoA carboxylase (in the present specification, sometimes to be abbreviated as ACC) inhibitory action, which is useful for the prophylaxis or treatment of obesity, diabetes, hypertension, hyperlipidemia, cardiac
Išsamiausia vaistinių žolelių duomenų bazė, paremta mokslu
Dirba 55 kalbomis
Žolelių gydymas, paremtas mokslu
Vaistažolių atpažinimas pagal vaizdą
Interaktyvus GPS žemėlapis - pažymėkite vaistažoles vietoje (netrukus)
Skaitykite mokslines publikacijas, susijusias su jūsų paieška
Ieškokite vaistinių žolelių pagal jų poveikį
Susitvarkykite savo interesus ir sekite naujienas, klinikinius tyrimus ir patentus
Įveskite simptomą ar ligą ir perskaitykite apie žoleles, kurios gali padėti, įveskite žolę ir pamatykite ligas bei simptomus, nuo kurių ji naudojama. * Visa informacija pagrįsta paskelbtais moksliniais tyrimais